Ravikumar, L. et al. 2023. Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus with Multiple Cardiovascular Risk Factors. Cardiology and Cardiovascular Medicine. 7, 2 (Apr. 2023), 141–144.